BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19907652)

  • 1. Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.
    Seidelin JB; Broom OJ; Olsen J; Nielsen OH
    PLoS One; 2009 Nov; 4(11):e7794. PubMed ID: 19907652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.
    Beynon V; Cotofana S; Brand S; Lohse P; Mair A; Wagner S; Mussack T; Ochsenkühn T; Folwaczny M; Folwaczny C; Glas J; Török HP
    Inflamm Bowel Dis; 2008 Aug; 14(8):1033-40. PubMed ID: 18383179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn's disease.
    Peeters H; Bogaert S; Laukens D; Rottiers P; De Keyser F; Darfeuille-Michaud A; Glasser AL; Elewaut D; De Vos M
    Int J Immunogenet; 2007 Jun; 34(3):181-91. PubMed ID: 17504508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of muramyl dipeptide-sensing pathway defects in monocytes of patients with Crohn's disease using phospho-specific whole blood flow cytometry.
    Kuuliala K; Lappalainen M; Turunen U; Puolakkainen P; Kemppainen E; Siitonen S; Repo H; Mustonen H
    Scand J Clin Lab Invest; 2013 Sep; 73(6):494-502. PubMed ID: 23837874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms.
    Linderson Y; Bresso F; Buentke E; Pettersson S; D'Amato M
    Int J Colorectal Dis; 2005 Jul; 20(4):305-11. PubMed ID: 15800781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
    Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
    Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of muramyl dipeptide-sensing pathway defects in patients with Crohn's disease.
    van Heel DA; Hunt KA; King K; Ghosh S; Gabe SM; Mathew CG; Forbes A; Playford RJ
    Inflamm Bowel Dis; 2006 Jul; 12(7):598-605. PubMed ID: 16804397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.
    Scharl M; Mwinyi J; Fischbeck A; Leucht K; Eloranta JJ; Arikkat J; Pesch T; Kellermeier S; Mair A; Kullak-Ublick GA; Truninger K; Noreen F; Regula J; Gaj P; Pittet V; Mueller C; Hofmann C; Fried M; McCole DF; Rogler G
    Inflamm Bowel Dis; 2012 May; 18(5):900-12. PubMed ID: 22021207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
    Salem M; Seidelin JB; Rogler G; Nielsen OH
    Cell Mol Life Sci; 2013 Sep; 70(18):3391-404. PubMed ID: 23275943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop.
    Begue B; Dumant C; Bambou JC; Beaulieu JF; Chamaillard M; Hugot JP; Goulet O; Schmitz J; Philpott DJ; Cerf-Bensussan N; Ruemmele FM
    J Cell Physiol; 2006 Nov; 209(2):241-52. PubMed ID: 16897777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease.
    Wang TT; Dabbas B; Laperriere D; Bitton AJ; Soualhine H; Tavera-Mendoza LE; Dionne S; Servant MJ; Bitton A; Seidman EG; Mader S; Behr MA; White JH
    J Biol Chem; 2010 Jan; 285(4):2227-31. PubMed ID: 19948723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NOD2-RICK complex signals from the plasma membrane.
    Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
    J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
    Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon gamma boosts the nucleotide oligomerization domain 2-mediated signaling pathway in human dendritic cells in an X-linked inhibitor of apoptosis protein and mammalian target of rapamycin-dependent manner.
    Fekete T; Koncz G; Szabo B; Gregus A; Rajnavölgyi E
    Cell Mol Immunol; 2017 Apr; 14(4):380-391. PubMed ID: 26521691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
    Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
    Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial peptide response to blood translocation of bacterial DNA in Crohn's disease is affected by NOD2/CARD15 genotype.
    Gutiérrez A; Holler E; Zapater P; Sempere L; Jover R; Pérez-Mateo M; Schoelmerich J; Such J; Wiest R; Francés R
    Inflamm Bowel Dis; 2011 Aug; 17(8):1641-50. PubMed ID: 21744420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.